{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:59:09Z","timestamp":1791277149253,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ijrobp.2013.11.241","type":"journal-article","created":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T04:47:14Z","timestamp":1392007634000},"page":"715-722","source":"Crossref","is-referenced-by-count":75,"title":["Dosimetric Considerations to Determine the Optimal Technique for Localized Prostate Cancer Among External\u00a0Photon, Proton, or Carbon-Ion Therapy and High-Dose-Rate or Low-Dose-Rate Brachytherapy"],"prefix":"10.1016","volume":"88","author":[{"given":"Dietmar","family":"Georg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Hopfgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"G\u00f2ra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kuess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Kragl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neamat","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Goldner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Georg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2013.11.241_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2010.02.022","article-title":"Subgroup analysis of patients with localized prostate cancer treated within the Dutch-randomized dose escalation trial","volume":"96","author":"Al-Mamgani","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib3","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1200\/JCO.2009.25.8475","article-title":"Randomized trial comparing conventional-dose with high dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group\/American College of Radiology 95-09","volume":"28","author":"Zietman","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0360-3016(03)00784-3","article-title":"Radical prostatectomy, external beam radiotherapy <72Gy, external beam radiotherapy > or =72Gy, permanent seed implantation, or combined seeds\/external beam radiotherapy for stage T1-T2 prostate cancer","volume":"58","author":"Kupelian","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijrobp.2011.11.047","article-title":"Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer","volume":"84","author":"Zelefsky","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib6","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ijrobp.2010.10.075","article-title":"Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: \u03b1\/\u03b2=1.4 (0.9-2.2) Gy","volume":"82","author":"Miralbell","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib7","first-page":"1084","article-title":"Risk factors of late rectal bleeding after carbon ion therapy for prostate cancer","volume":"66","author":"Ishikawa","year":"2006","journal-title":"Int J RadiatOncolBiol Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/pros.10328","article-title":"Phase I\/II clinical trials of carbon ion therapy for prostate cancer","volume":"58","author":"Akakura","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.radonc.2012.01.016","article-title":"Comparison between external beam radiotherapy (70 Gy\/74 Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patients","volume":"103","author":"Goldner","year":"2012","journal-title":"Radiother Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.ijrobp.2013.11.241_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2011.10827.x","article-title":"Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group","volume":"109","author":"Grimm","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib11","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.ijrobp.2011.04.031","article-title":"High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence","volume":"82","author":"Hoskin","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.radonc.2013.05.002","article-title":"GEC\/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update","volume":"107","author":"Hoskin","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib13","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.ijrobp.2011.01.039","article-title":"Comparison of high-dose proton radiotherapy and brachytherapy in localizedprostate cancer: A case-matched analysis","volume":"82","author":"Coen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijrobp.2009.07.1680","article-title":"Urinary obstruction in prostate cancer patients from the Dutch trial (68 Gy vs.78 Gy): Relationships with local dose, acute effects, and baseline characteristics","volume":"78","author":"Heemsbergen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib15","doi-asserted-by":"crossref","first-page":"853487","DOI":"10.1155\/2012\/853487","article-title":"Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer","volume":"2012","author":"Hunter","year":"2012","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib16","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/j.1464-410X.2012.11385.x","article-title":"Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: Incidence and cause-specific survival outcomes according to the initial treatment intervention","volume":"110","author":"Zelefsky","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.radonc.2011.10.005","article-title":"IGRT induced dose burden for a variety of imaging protocols at two different anatomical sites","volume":"102","author":"Stock","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.ijrobp.2012.05.046","article-title":"Is there an advantage in designing adapted, patient-specific PTV margins in intensity modulated proton beam therapy for prostate cancer?","volume":"85","author":"G\u00f3ra","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib19","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ijrobp.2012.01.072","article-title":"Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: From 20 to 16 fractions","volume":"84","author":"Okada","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib20","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1088\/0031-9155\/45\/11\/313","article-title":"Treatment planning for heavy-ion radiotherapy: Physical beam model and dose optimization","volume":"45","author":"Kr\u00e4mer","year":"2000","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib21","doi-asserted-by":"crossref","first-page":"041704","DOI":"10.1118\/1.4793766","article-title":"A gEUD-based inverse planning technique for HDR prostate brachytherapy: Feasibility study","volume":"40","author":"Giantsoudi","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib22","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1118\/1.3694110","article-title":"A novel curvilinear approach for prostate seed implantation","volume":"39","author":"Podder","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib23","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1118\/1.1568978","article-title":"CERR: A computational environment for radiotherapy research","volume":"30","author":"Deasy","year":"2003","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijrobp.2012.03.004","article-title":"Meta analysis of alpha\/beta ratio for prostate cancer in the presence of an overall time factor. Bad news,\u00a0good news or no news?","volume":"85","author":"Vogelius","year":"2013","journal-title":"Int J Radiat Oncology Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib25","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ijrobp.2004.04.014","article-title":"Fractionation and late rectal toxicity","volume":"60","author":"Brenner","year":"2004","journal-title":"Int J Radiat Oncology Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijrobp.2009.03.078","article-title":"Radiation dose-volume effects in radiation-induced rectal injury","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncology Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib27","doi-asserted-by":"crossref","unstructured":"Herrmann T, Baumann M, D\u00f6rr W, eds. Klinische Strahlenbiologie: Kurz und B\u00fcndig. 4th ed. Amsterdam: Elsevier-Urban-Fischer.","DOI":"10.1007\/978-3-642-95963-9"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib28","series-title":"The Role of Dose Rate in Brachytherapy","first-page":"69","author":"Dutreix","year":"1997"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eururo.2011.09.027","article-title":"Functional outcomes and complications following radiation therapy for prostate cancer: A critical analysis of the literature","volume":"61","author":"Bud\u00e4us","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0360-3016(01)01442-0","article-title":"Defining the risk of developing grade 2 proctitis following 125-I prostate brachytherapy using a rectal dose-volume histogram analysis","volume":"50","author":"Snyder","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib31","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijrobp.2009.07.1723","article-title":"Biochemical disease-free rate and toxicity for men treated with iodine-125 prostate brachytherapy with D(90) \u2265180 Gy","volume":"78","author":"G\u00f3mez-Iturriaga Pi\u00f1a","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib32","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijrobp.2010.05.027","article-title":"Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities","volume":"81","author":"Nihei","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijrobp.2010.09.024","article-title":"Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer","volume":"82","author":"Mendenhall","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.semradonc.2012.11.005","article-title":"Health economic controversy and cost-effectiveness of proton therapy","volume":"23","author":"Lievens","year":"2013","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2013.11.241_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.radonc.2013.04.027","article-title":"Boosting imaging defined dominant prostatic tumors: A systematic review","volume":"107","author":"Bauman","year":"2013","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161303602X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161303602X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T19:27:31Z","timestamp":1538854051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161303602X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S036030161303602X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2013.11.241","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}